Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

ract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease and is administered by intramuscular injection. Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD), infants with a history of premature birth (less than or equal to 35 weeks gestation age), and children with hemodynamically significant CHD. Synagis has been used in more than one million children in the U.S. since its introduction in 1998. The first dose of Synagis should be administered prior to commencement of the RSV season. Patients, including those who develop an RSV infection, should continue to receive monthly doses throughout the season.

Very rare cases (<1 per 100,000 patients) of anaphylaxis and rare (<1 per 1,000 patients) hypersensitivity reactions have been reported with Synagis. Cases of anaphylaxis were reported following re-exposure to Synagis and rare severe hypersensitivity reactions occurred on initial exposure or re-exposure. If a severe hypersensitivity reaction occurs, therapy with Synagis should be permanently discontinued. If milder hypersensitivity reaction occurs, caution should be used on re-administration of Synagis.

In clinical trials, the most common adverse events occurring at least 1 percent more frequently in Synagis-treated patients than controls were upper respiratory infection, otitis media, fever and rhinitis. Cyanosis and arrhythmia were seen in children with CHD.

For full prescribing information for Synagis, see the company's website at: www.medimmune.com/products/synagis/index.asp.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the ar
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/2/2015)... , July 2, 2015 Numotion,s Board ... Officer announced that Tamas Feitel has joined ... joins Numotion after a highly successful 18 year career ... roles driving strategy, profitability, and productivity to result in ... recent position was Chief Financial Officer for GE Healthcare ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... its acquisition of assets related to the ion channel ... that had previously been obtained as part of Pfizer,s ... all of Pfizer,s rights to the "Icagen" name and ... will provide comprehensive services for ion channel and transporter ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... BehaviorCorp as medical director in 1990, Dr, Jerry Sheward, ... medical records (EMR) to enable the multi-location behavior health ... adults and children in the Indianapolis area and across ... apart from residing on a reliable but closed operating ...
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... interactive website, www.solosendoscopy.com on Friday July 1, ... for existing and new customers and includes comprehensive information ... look showcases streamlined navigation to allow for easy-to-use functionality, ...
Cached Medicine Technology:Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 2Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 3Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices 4Solos Endoscopy, Inc. To Launch New Corporate Website 2
(Date:7/2/2015)... ... July 02, 2015 , ... As the world becomes more connected ... how they interact with products in their everyday lives. Technology can now help homeowners ... to home entertainment and safety, as well as making kitchen tasks simpler. ...
(Date:7/2/2015)... ... , ... no secret that what we consume can have an effect on the body. And during the ... or perhaps even undernourished if not eating enough of the right foods, as well as drinking ... of year to overdo it on the food front as well, with sweet treats like ice ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... California Department of State Hospitals. Prior to using Winscribe’s dictation and clinical documentation ... dictation system to manage their organization’s dictation and transcription processes. , ...
(Date:7/2/2015)... Chicago (PRWEB) , ... July 02, 2015 , ... ... companies innovate across their products, services, channels and business models. To help manage ... is announcing the addition of Mark Benkendorf as SVP of Strategic Engagements. , ...
(Date:7/1/2015)... Livonia, Mich. (PRWEB) , ... July 01, 2015 ... ... the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., ... "With the closing today, we have gained an admirable and important partner committed ...
Breaking Medicine News(10 mins):Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 2Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 3Health News:KillerApps.TV Teams with Mario Armstrong to Feature Smart Home Technology 4Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 2Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 3Health News:Patton State Hospital Saves Over 50% and Removes Document Backlogs with Winscribe Text 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4
... sideline even the best athletes, but a new study ... indicates that the use of minimally invasive arthroscopic surgery ... athletes who undergo the procedure another opportunity to resume ... , The researchers at Rush determined that 78 percent ...
... Gardner HealthDay Reporter , SUNDAY, July 18 ... participate in clinical trials for HIV vaccines end up ... they,re not actually infected, a new study shows. ... (VISP), meaning that they possess immune system antibodies to ...
... Sayadi and Joel Herskowitz. They are a wife-husband team ... problems are everywhere and they can be deadly., "Many ... the elderly," said Sayadi, a speech-language pathologist with the Natick ... many things to prevent falls. But not many people realize ...
... of Technology not only involves its students in research, ... innovations. An example of recently licensed university technology is ... in the laboratory. Associate Professor Nasri Nesnas was ... a commonly used laboratory research tool. Most often, neuroscientists ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, July ... panel recommended that the controversial diabetes drug Avandia stay on ... organizations are urging patients not to change their medications before ... use of Avandia to drop off markedly, however. "Why ...
... prey, chemical signals called kairomones serve as an early-warning ... detected by their prey, and can even trigger adaptations, ... help protect the prey. But as widespread as kairomones ... remained largely unknown. New research by Rockefeller University,s Joel ...
Cached Medicine News:Health News:New study finds arthroscopic hip surgery may fully restore function in athletes 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 2Health News:Many False-Positive HIV Test Results for Those in AIDS Vaccine Trials 3Health News:Swallowing safely is no choke 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 2Health News:Diabetics Urged to Confer With Their Doctor About Avandia Use 3Health News:Scientists identify nature's insect repellents 2
... Digital Flexible Ureteroscope (DUR-D) incorporates many ... proven durable, market leading DUR® series ... first device utilizing Gyrus ACMIs proprietary, ... Metal Oxide Semi-Conductor (CMOS) distal sensor ...
... is the first one-step 20 minutes rapid test ... 2 produced by Enterohemorrhagic Escherichia coli in human ... enrichment of fecal specimens and detects all Toxigenic ... separate result for Toxin 1 and 2 is ...
Inquire...
... elegant and sophisticated woman, the ... ophthalmic and sunwear styles. Frames ... of shapes and colors, designed ... and complexions. Many styles feature ...
Medicine Products: